Standalone Trabeculotomy and Viscodilation of Schlemm’s Canal and Collector Channels in Open-Angle Glaucoma Using the OMNI Surgical System: 24-Month Outcomes

Karsten Klabe, Hakan Kaymak Breyer-Kaymak-Klabe Augenchirurgie, Duesseldorf, GermanyCorrespondence: Karsten KlabeBreyer-Kaymak-Klabe Augenchirurgie, Martin Luther Platz 22, Duesseldorf, 40212, GermanyTel +49 211 5867570Fax +49 211 58675799Email k.klabe@augenchirurgie.clinicPurpose: Intraocular press...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Klabe K, Kaymak H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/5fbd7c986821466e93ac457df171e4d6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5fbd7c986821466e93ac457df171e4d6
record_format dspace
spelling oai:doaj.org-article:5fbd7c986821466e93ac457df171e4d62021-12-02T17:55:07ZStandalone Trabeculotomy and Viscodilation of Schlemm&rsquo;s Canal and Collector Channels in Open-Angle Glaucoma Using the OMNI Surgical System: 24-Month Outcomes1177-5483https://doaj.org/article/5fbd7c986821466e93ac457df171e4d62021-07-01T00:00:00Zhttps://www.dovepress.com/standalone-trabeculotomy-and-viscodilation-of-schlemms-canal-and-colle-peer-reviewed-fulltext-article-OPTHhttps://doaj.org/toc/1177-5483Karsten Klabe, Hakan Kaymak Breyer-Kaymak-Klabe Augenchirurgie, Duesseldorf, GermanyCorrespondence: Karsten KlabeBreyer-Kaymak-Klabe Augenchirurgie, Martin Luther Platz 22, Duesseldorf, 40212, GermanyTel +49 211 5867570Fax +49 211 58675799Email k.klabe@augenchirurgie.clinicPurpose: Intraocular pressure (IOP), medication outcomes at 24 months following trabeculotomy/viscodilation using the OMNI® surgical system as a standalone procedure in medically uncontrolled mild–moderate open-angle glaucoma (OAG).Setting: Surgical center (Duesseldorf, Germany).Design: Retrospective analysis. IOP and medication data were collected before surgery and through 24 months. Safety data included adverse events and the need for additional surgery.Methods: Pre-op medication washout. Goldmann tonometry. Number of medications and adverse events (AE) at each time point. Primary outcomes: changes in IOP and medications. Two-sided paired t-tests compare values at each follow-up with baseline, significance p = 0.05. Secondary outcomes: proportion of eyes with IOP reduction of ≥ 20%, on fewer medications, and medication-free at each time point.Results: This analysis included data from 38 eyes of 27 subjects. Mean (standard deviation) baseline IOP was 24.6 (3.0) mmHg and through 24 months ranged from 12.6 to 14.9 mmHg (p < 0.0001), representing reductions of 10.0– 12.0 mmHg. Mean medications were 1.9 (baseline) and through 24 months ranged from 0.0 to 0.5 (70.6– 100% reduction) (p < 0.0001). At Month 24, mean IOP was 14.9 mmHg (− 10.0 mmHg), and 100% of eyes achieved IOP reduction > 20% from baseline; mean medication use was 0.5 (− 1.4 medications, p < 0.0001), 84.6% of eyes using > 1 fewer medication, and 57.7% were medication-free. The most common adverse event was intraoperative hyphema (44.7%); all resolved spontaneously. There were two secondary procedures for IOP control.Conclusion: The OMNI surgical system provides clinically relevant and statistically significant reductions in both IOP and medications with an excellent safety profile and should be considered in phakic or pseudophakic eyes with mild–moderate OAG requiring IOP or medication reduction, or both.Keywords: primary open-angle glaucoma, trabeculotomy, viscodilation, OMNI surgical systemKlabe KKaymak HDove Medical Pressarticleprimary open-angle glaucomatrabeculotomyviscodilationomni surgical systemOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 15, Pp 3121-3129 (2021)
institution DOAJ
collection DOAJ
language EN
topic primary open-angle glaucoma
trabeculotomy
viscodilation
omni surgical system
Ophthalmology
RE1-994
spellingShingle primary open-angle glaucoma
trabeculotomy
viscodilation
omni surgical system
Ophthalmology
RE1-994
Klabe K
Kaymak H
Standalone Trabeculotomy and Viscodilation of Schlemm&rsquo;s Canal and Collector Channels in Open-Angle Glaucoma Using the OMNI Surgical System: 24-Month Outcomes
description Karsten Klabe, Hakan Kaymak Breyer-Kaymak-Klabe Augenchirurgie, Duesseldorf, GermanyCorrespondence: Karsten KlabeBreyer-Kaymak-Klabe Augenchirurgie, Martin Luther Platz 22, Duesseldorf, 40212, GermanyTel +49 211 5867570Fax +49 211 58675799Email k.klabe@augenchirurgie.clinicPurpose: Intraocular pressure (IOP), medication outcomes at 24 months following trabeculotomy/viscodilation using the OMNI® surgical system as a standalone procedure in medically uncontrolled mild–moderate open-angle glaucoma (OAG).Setting: Surgical center (Duesseldorf, Germany).Design: Retrospective analysis. IOP and medication data were collected before surgery and through 24 months. Safety data included adverse events and the need for additional surgery.Methods: Pre-op medication washout. Goldmann tonometry. Number of medications and adverse events (AE) at each time point. Primary outcomes: changes in IOP and medications. Two-sided paired t-tests compare values at each follow-up with baseline, significance p = 0.05. Secondary outcomes: proportion of eyes with IOP reduction of ≥ 20%, on fewer medications, and medication-free at each time point.Results: This analysis included data from 38 eyes of 27 subjects. Mean (standard deviation) baseline IOP was 24.6 (3.0) mmHg and through 24 months ranged from 12.6 to 14.9 mmHg (p < 0.0001), representing reductions of 10.0– 12.0 mmHg. Mean medications were 1.9 (baseline) and through 24 months ranged from 0.0 to 0.5 (70.6– 100% reduction) (p < 0.0001). At Month 24, mean IOP was 14.9 mmHg (− 10.0 mmHg), and 100% of eyes achieved IOP reduction > 20% from baseline; mean medication use was 0.5 (− 1.4 medications, p < 0.0001), 84.6% of eyes using > 1 fewer medication, and 57.7% were medication-free. The most common adverse event was intraoperative hyphema (44.7%); all resolved spontaneously. There were two secondary procedures for IOP control.Conclusion: The OMNI surgical system provides clinically relevant and statistically significant reductions in both IOP and medications with an excellent safety profile and should be considered in phakic or pseudophakic eyes with mild–moderate OAG requiring IOP or medication reduction, or both.Keywords: primary open-angle glaucoma, trabeculotomy, viscodilation, OMNI surgical system
format article
author Klabe K
Kaymak H
author_facet Klabe K
Kaymak H
author_sort Klabe K
title Standalone Trabeculotomy and Viscodilation of Schlemm&rsquo;s Canal and Collector Channels in Open-Angle Glaucoma Using the OMNI Surgical System: 24-Month Outcomes
title_short Standalone Trabeculotomy and Viscodilation of Schlemm&rsquo;s Canal and Collector Channels in Open-Angle Glaucoma Using the OMNI Surgical System: 24-Month Outcomes
title_full Standalone Trabeculotomy and Viscodilation of Schlemm&rsquo;s Canal and Collector Channels in Open-Angle Glaucoma Using the OMNI Surgical System: 24-Month Outcomes
title_fullStr Standalone Trabeculotomy and Viscodilation of Schlemm&rsquo;s Canal and Collector Channels in Open-Angle Glaucoma Using the OMNI Surgical System: 24-Month Outcomes
title_full_unstemmed Standalone Trabeculotomy and Viscodilation of Schlemm&rsquo;s Canal and Collector Channels in Open-Angle Glaucoma Using the OMNI Surgical System: 24-Month Outcomes
title_sort standalone trabeculotomy and viscodilation of schlemm&rsquo;s canal and collector channels in open-angle glaucoma using the omni surgical system: 24-month outcomes
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/5fbd7c986821466e93ac457df171e4d6
work_keys_str_mv AT klabek standalonetrabeculotomyandviscodilationofschlemmrsquoscanalandcollectorchannelsinopenangleglaucomausingtheomnisurgicalsystem24monthoutcomes
AT kaymakh standalonetrabeculotomyandviscodilationofschlemmrsquoscanalandcollectorchannelsinopenangleglaucomausingtheomnisurgicalsystem24monthoutcomes
_version_ 1718379109078269952